High prevalence of hepatitis C virus but not HIV co-infection among patients with tuberculosis in Georgia

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 4, 2006, Pages 396-401

  Richards, D C ^a   Mikiashvili, T ^a   Parris, J J ^a   Kourbatova, E V ^a,b   Wilson, J C E ^a   Shubladze, N ^c   Tsertvadze, T ^d   Khechinashvili, G ^c   Del Rio, C ^a   Blumberg, Henry M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAMARA NATIONAL RESEARCH UNIVERSITY   (Russian Federation)

^c National Center of Tuberculosis and Lung Diseases   (Georgia)

^d AIDS and Clinical Immunology Research Center   (Georgia)

Author keywords

Hepatitis C virus (HCV); HIV; Republic of Georgia; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH; SERODIAGNOSIS; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; TATTOOING; TUBERCULOSIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; FEMALE; GEORGIA (REPUBLIC); HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 33645673899     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Weinstock D M, Hahn O, Wittkamp M, Sepkowitz K A, Khechinashvili G, Blumberg H M. Risk for tuberculosis infection among internally displaced persons in the Republic of Georgia. Int J Tuberc Lung Dis 2001; 5: 164-169.
2. Zalesky R, Abdullajev F, Khechinashvili G, et al. Tuberculosis control in the Caucasus: successes and constraints in DOTS implementation. Int J Tuberc Lung Dis 1999; 3: 394-401.
3. Frieden T R, Sterling T R, Munsiff S S, Watt C J, Dye C. Tuberculosis. Lancet 2003; 362: 887-899.
4. Khechinashvili G, Mdivani N, Blumberg H M. Lessons learned from implementation of DOTS (directly observed therapy, short course) tuberculosis control strategy in the Republic of Georgia. In: 42nd Annual Meeting of Infectious Diseases Society of America. Boston, MA: Infectious Diseases Society of America, October 2004.
5. Mdivani N, Zangaladze E, Volkova N, et al. High rates and risk factors for multidrug resistant tuberculosis (MDR-TB) in the Republic of Georgia. In: 36th Union World Conference on Lung Health. Paris, France: International Union Against Tuberculosis and Lung Disease, October 2005.
6. Aerts A, Habouzit M, Mschiladze, et al. Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nationwide prevalence survey among sentenced inmates. Int J Tuberc Lung Dis 2000; 4: 1104-1109.
7. Corbett E L, Watt C J, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021.
8. Butsashvili M, Tsertsvadze T, McNutt L A, Kamkamidze G, Gvetadze R, Badridze N. Prevelance of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors. Eur J Epidemiol 2001; 17: 693-695.
9. Tkeshelashvili-Kessler A, del Rio C, Nelson K, Tsertsvadze T. The emerging HIV/AIDS epidemic in Georgia. Int J STD AIDS 2005; 16: 61-67.
10. Lauer G M, Walker B D. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
11. Rockstroh J K, Spengler U. HIV and hepatitis C virus co-infection. Lancet Infect Dis 2004; 4: 437-444.
12. Zaller N, Nelson K E, Aladashvili M, Badridze N, del Rio C, Tsertsvadze T. Risk factors for hepatitis C virus infection among blood donors in Georgia. Eur J Epidemiol 2004; 19: 547-553.
13. Blumberg H M, Burman W J, Chaisson R E, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
14. Ungo J R, Jones D, Ashkin D, et al. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med 1998; 157: 1871-1876.
15. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. WHO/CDS/TB/2003.313. 3rd ed. Geneva: WHO, 2003. www.who.int/docstore/gtb/publications/ttgnp/ Accessed April 2005.
16. El-Serag H B, Anand B, Richardson P, Rabeneck L. Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol 2003; 98: 167-174.
17. Hellard M E, Hocking J S, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect 2004; 132: 409-415.
18. de Nishioka S A, Gyorkos T W, Joseph L, Collet J P, MacLean J D. Tattooing and transfusion-transmitted diseases in Brazil: a hospital-based cross-sectional matched study. Eur J Epidemiol 2003; 18: 441-449.
19. Haley R W, Fischer R P. The tattooing paradox: are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection? Arch Intern Med 2003; 163: 1095-1098.
20. Stern V. Problems in prisons worldwide, with a particular focus on Russia. Ann N Y Acad Sci 2001; 953: 113-119.
21. Allwright S, Bradley F, Long J, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 2000; 321: 78-82.
22. Toungoussova O S, Mariandyshev A, Bjune G, Sandven P, Caugant D A. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin Infect Dis 2003; 37: 665-672.
23. Wyld R, Robertson J R, Brettle R P, Mellor J, Prescott L, Simmonds P. Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals. J Infect 1997; 35: 163-166.
24. Alter M J, Kruszon-Moran D, Nainan O V, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562.